297 related articles for article (PubMed ID: 32452892)
21. Eradication therapy is effective for Helicobacter pylori-negative gastric mucosa-associated lymphoid tissue lymphoma.
Asano N; Iijima K; Terai S; Jin X; Ara N; Chiba T; Fushiya J; Koike T; Imatani A; Shimosegawa T
Tohoku J Exp Med; 2012 Nov; 228(3):223-7. PubMed ID: 23076291
[TBL] [Abstract][Full Text] [Related]
22. Increased plasmacytic differentiation in gastric mucosa-associated lymphoid tissue lymphomas: Helicobacter pylori eradication response and IgG4+ plasma cell association.
Park S; Ahn S; Hong M; Ko YH
Hum Pathol; 2017 Jan; 59():113-119. PubMed ID: 27697589
[TBL] [Abstract][Full Text] [Related]
23. Predictive value of endoscopic ultrasonography for regression of gastric low grade and high grade MALT lymphomas after eradication of Helicobacter pylori.
Nakamura S; Matsumoto T; Suekane H; Takeshita M; Hizawa K; Kawasaki M; Yao T; Tsuneyoshi M; Iida M; Fujishima M
Gut; 2001 Apr; 48(4):454-60. PubMed ID: 11247887
[TBL] [Abstract][Full Text] [Related]
24. Antibiotic treatment as sole management of Helicobacter pylori-negative gastric MALT lymphoma: a single center experience with prolonged follow-up.
Raderer M; Wöhrer S; Kiesewetter B; Dolak W; Lagler H; Wotherspoon A; Muellauer L; Chott A
Ann Hematol; 2015 Jun; 94(6):969-73. PubMed ID: 25579756
[TBL] [Abstract][Full Text] [Related]
25. Long-term clinical outcome of Helicobacter pylori eradication for gastric mucosa-associated lymphoid tissue lymphoma with a reference to second-line treatment.
Nakamura S; Matsumoto T; Suekane H; Nakamura S; Matsumoto H; Esaki M; Yao T; Iida M
Cancer; 2005 Aug; 104(3):532-40. PubMed ID: 15937928
[TBL] [Abstract][Full Text] [Related]
26. [Prognostic impact of Helicobacter pylori infection and eradication therapy in gastric mucosa-associated lymphoid tissue lymphoma].
Park SH; Chi HS; Park SJ; Jang S; Park CJ; Huh JR
Korean J Lab Med; 2010 Dec; 30(6):547-53. PubMed ID: 21157137
[TBL] [Abstract][Full Text] [Related]
27. Impaired response of gastric MALT-lymphoma to Helicobacter pylori eradication in patients with autoimmune disease.
Raderer M; Osterreicher C; Machold K; Formanek M; Fiebiger W; Penz M; Dragosics B; Chott A
Ann Oncol; 2001 Jul; 12(7):937-9. PubMed ID: 11521798
[TBL] [Abstract][Full Text] [Related]
28. Helicobacter pylori infection and gastric MALTomas: an up-to-date and therapy highlight.
Santacroce L; Cagiano R; Del Prete R; Bottalico L; Sabatini R; Carlaio RG; Prejbeanu R; Vermesan H; Dragulescu SI; Vermesan D; Motoc A; Losacco T
Clin Ter; 2008; 159(6):457-62. PubMed ID: 19169609
[TBL] [Abstract][Full Text] [Related]
29. Effect of Helicobacter pylori eradication therapy on the response of MALT-Gastric lymphoma.
Dabbebi H; Elloumi H; Kechiche C; Hammemi E; Cheikh I; Jmaa A
Tunis Med; 2022 Janvier; 100(1):37-43. PubMed ID: 35822330
[TBL] [Abstract][Full Text] [Related]
30. Eradication therapy in Helicobacter pylori-negative, gastric low-grade mucosa-associated lymphoid tissue lymphoma patients: a systematic review.
Zullo A; Hassan C; Ridola L; De Francesco V; Rossi L; Tomao S; Vaira D; Genta RM
J Clin Gastroenterol; 2013; 47(10):824-7. PubMed ID: 23442842
[TBL] [Abstract][Full Text] [Related]
31. The role of Helicobacter pylori eradication in the treatment of diffuse large B-cell and marginal zone lymphomas of the stomach.
Ferreri AJ; Govi S; Ponzoni M
Curr Opin Oncol; 2013 Sep; 25(5):470-9. PubMed ID: 23942292
[TBL] [Abstract][Full Text] [Related]
32. Gastric MALT-lymphoma, gastrin and cyclooxygenases.
Konturek PC; Konturek SJ; Pierzchalski P; Starzyńska T; Marlicz K; Hartwich A; Zuchowicz M; Darasz Z; Papiez D; Hahn EG
Acta Gastroenterol Belg; 2002; 65(1):17-23. PubMed ID: 12014312
[TBL] [Abstract][Full Text] [Related]
33. Eradication therapy for Helicobacter pylori in patients with gastric MALT lymphoma: a pooled data analysis.
Zullo A; Hassan C; Andriani A; Cristofari F; De Francesco V; Ierardi E; Tomao S; Morini S; Vaira D
Am J Gastroenterol; 2009 Aug; 104(8):1932-7; quiz 1938. PubMed ID: 19532131
[TBL] [Abstract][Full Text] [Related]
34. Helicobacter pylori eradication and remission of low-grade gastric mucosa-associated lymphoid tissue lymphoma: a long-term follow-up study.
Papa A; Cammarota G; Tursi A; Gasbarrini A; Gasbarrini G
J Clin Gastroenterol; 2000 Sep; 31(2):169-71. PubMed ID: 10993438
[TBL] [Abstract][Full Text] [Related]
35. Predictive factors for regression of gastric MALT lymphoma after anti-Helicobacter pylori treatment.
Ruskoné-Fourmestraux A; Lavergne A; Aegerter PH; Megraud F; Palazzo L; de Mascarel A; Molina T; Rambaud JL
Gut; 2001 Mar; 48(3):297-303. PubMed ID: 11171816
[TBL] [Abstract][Full Text] [Related]
36. Eradication of Helicobacter pylori and stability of remissions in low-grade gastric B-cell lymphomas of the mucosa-associated lymphoid tissue: results of an ongoing multicenter trial.
Thiede C; Wündisch T; Neubauer B; Alpen B; Morgner A; Ritter M; Ehninger G; Stolte M; Bayerdörffer E; Neubauer A
Recent Results Cancer Res; 2000; 156():125-33. PubMed ID: 10802872
[TBL] [Abstract][Full Text] [Related]
37. [Helicobacter pylori eradication for stage I(E₁) gastric mucosa-associated lymphoid tissue lymphoma: predictive factors of complete remission].
Kim SJ; Yang S; Min BH; Lee JH; Rhee PL; Rhee JC; Kim JJ
Korean J Gastroenterol; 2010 Feb; 55(2):94-9. PubMed ID: 20168055
[TBL] [Abstract][Full Text] [Related]
38. Long-term clinical outcome of gastric MALT lymphoma after eradication of Helicobacter pylori: a multicentre cohort follow-up study of 420 patients in Japan.
Nakamura S; Sugiyama T; Matsumoto T; Iijima K; Ono S; Tajika M; Tari A; Kitadai Y; Matsumoto H; Nagaya T; Kamoshida T; Watanabe N; Chiba T; Origasa H; Asaka M;
Gut; 2012 Apr; 61(4):507-13. PubMed ID: 21890816
[TBL] [Abstract][Full Text] [Related]
39. Investigation of endoscopic findings in nine cases of Helicobacter suis-infected gastritis complicated by gastric mucosa-associated lymphoid tissue lymphoma.
Kadota H; Yuge R; Miyamoto R; Otani R; Takigawa H; Hayashi R; Urabe Y; Oka S; Sentani K; Oue N; Kitadai Y; Tanaka S
Helicobacter; 2022 Jun; 27(3):e12887. PubMed ID: 35363918
[TBL] [Abstract][Full Text] [Related]
40. Mucosal change of the stomach with low-grade mucosa-associated lymphoid tissue lymphoma after eradication of Helicobacter pylori: follow-up study of 48 cases.
Begum S; Sano T; Endo H; Kawamata H; Urakami Y
J Med Invest; 2000 Feb; 47(1-2):36-46. PubMed ID: 10740978
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
